Fabrication and Properties of Zn-Containing Intermetallic Compounds as Sacrificial Anodes of Zn-Based Implants

In the field of degradable metals, Zn-based implants have gradually gained more attention. However, the relatively slow degradation rate compared with the healing rate of the damaged bone tissue, along with the excessive Zn²⁺ release during the degradation process, limit the application of Zn-based implants. The use of intermetallic compounds with more negative electrode potentials as sacrificial anodes of Zn-based implants is likely to be a feasible approach to resolve this contradiction. In this work, three intermetallic compounds, MgZn₂, CaZn₁₃, and Ca₂Mg₆Zn₃, were prepared. The phase structures, microstructures, and relevant properties, such as thermal stability, in vitro degradation properties, and cytotoxicity of the compounds, were investigated. The XRD patterns indicate that the MgZn₂ and CaZn₁₃ specimens contain single-phase MgZn₂ and CaZn₁₃, respectively, while the Ca₂Mg₆Zn₃ specimen contains Mg₂Ca and Ca₂Mg₆Zn₃ phases. After purifying treatment in 0.9% NaCl solution, high purity Ca₂Mg₆Zn₃ phase was obtained. Thermal stability tests suggest that the MgZn₂ and CaZn₁₃ specimens possess good thermal stability below 773 K. However, the Ca₂Mg₆Zn₃ specimen melted at around 739.1 K. Polarization curve tests show that the corrosion potentials of MgZn₂, CaZn₁₃, and Ca₂Mg₆Zn₃ in simulated body fluid (SBF) were -1.063 V_SCE, -1.289 V_SCE, and -1.432 V_SCE, which were all more negative than that of the pure Zn specimen (-1.003 V_SCE). Clearly, these compounds can act as sacrificial anodes in Zn-based implants. The immersion tests indicate that these compounds were degraded according to the atomic ratio of the elements in each compound. Besides that, the compounds can efficiently induce Ca-P deposition in SBF. Cytotoxicity tests demonstrate that the 10% extracts prepared from these compounds exhibit good cell activity on MC3T3-E1 cells.